Proteus Biomedical's Raisin system
Intelligent medicine platform developer Proteus Biomedical has changed its name to Proteus Digital Health, to "better reflect" what the company does, Chief Product Officer David O'Reilly told MobiHealthNews in an email this week. Proteus also inked a deal with Japan-based Otsuka Pharmaceutical, which is known for its Abilify drug for schizophrenia and bipolar...
Proteus Biomedical announced today that it has received a patent for its ingestible biomedical sensor -- what the company has referred to as "intelligent medicine" in the past and what many have referred to as a "chip in a pill." The patent announcement also included new information about Proteus' partners: While the Novartis relationship had been previously announced, the company said it was...
The FDA announced today that it has cleared Proteus Biomedical's wireless, adhesive sensor technology Raisin, which can track and record a patient's heart rate, physical activity, body position and other biometrics. Raisin then transmits the data via Bluetooth to a PC or mobile device. Proteus explains that the Raisin device is worn just like a bandaid.
Raisin, however, is just one part of the...